Corbus Pharmaceuticals Holdings, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.27 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-10
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$1.27M.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$580.18K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$45.43K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$41.69K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$707.43K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$353.03K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$114.04K.
- Corbus Pharmaceuticals Holdings, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$64.45K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2018-03-31 | -$1.27M 10-Q · filed 2018-05-10 | -$1.85M derived: sum of 2 quarters · filed 2018-05-10 | -$1.90M derived: sum of 3 quarters · filed 2018-05-10 | -$1.94M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | -$580.18K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$625.61K derived: sum of 2 quarters · filed 2018-03-12 | -$667.30K derived: sum of 3 quarters · filed 2018-03-12 | -$707.43K 10-K · filed 2018-03-12 |
| 2017-09-30 | -$45.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$87.11K derived: sum of 2 quarters · filed 2017-11-08 | -$127.25K 10-Q · filed 2017-11-08 | -$223.26K derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-06-30 | -$41.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$81.82K 10-Q · filed 2017-08-09 | -$177.83K derived: sum of 3 quarters · filed 2018-05-10 | -$247.70K derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-03-31 | -$40.13K 10-Q · filed 2018-05-10 | -$136.15K derived: sum of 2 quarters · filed 2018-05-10 | -$206.01K derived: sum of 3 quarters · filed 2018-05-10 | -$327.84K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | -$96.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$165.88K derived: sum of 2 quarters · filed 2018-03-12 | -$287.71K derived: sum of 3 quarters · filed 2018-03-12 | -$353.03K 10-K · filed 2018-03-12 |
| 2016-09-30 | -$69.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$191.69K derived: sum of 2 quarters · filed 2017-11-08 | -$257.01K 10-Q · filed 2017-11-08 | -$350.01K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$121.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$187.15K 10-Q · filed 2017-08-09 | -$280.15K derived: sum of 3 quarters · filed 2018-03-12 | -$284.97K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | -$65.32K 10-Q · filed 2017-05-09 | -$158.32K derived: sum of 2 quarters · filed 2018-03-12 | -$163.14K derived: sum of 3 quarters · filed 2018-03-12 | -$177.63K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | -$93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$97.81K derived: sum of 2 quarters · filed 2018-03-12 | -$112.31K derived: sum of 3 quarters · filed 2018-03-12 | -$114.04K 10-K · filed 2018-03-12 |
| 2015-09-30 | -$4.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$19.31K derived: sum of 2 quarters · filed 2016-11-10 | -$21.04K 10-Q · filed 2016-11-10 | -$21.04K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$14.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$16.22K 10-Q · filed 2016-08-12 | -$16.22K derived: sum of 3 quarters · filed 2016-08-12 | -$72.66K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | -$1.73K 10-Q · filed 2016-05-13 | -$1.73K derived: sum of 2 quarters · filed 2016-05-13 | -$58.17K derived: sum of 3 quarters · filed 2016-05-13 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$56.44K derived: sum of 2 quarters · filed 2016-03-28 | -$64.45K 10-K · filed 2016-03-28 | |
| 2014-09-30 | -$56.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$64.45K 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | -$8.01K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |